GeneFrontier, formed as an solution provider for genome-based drug research & development, has the strengths of two shareholders:

- Business creation expertise and broad business network of ITX Corporation,
- Biotechnology and extensive clinical laboratory experience of BML, Inc.,

Human Combinatiorial Monoclonal Antibody Service

“Koutai Shokunin” represents Customized Human Monoclonal Antibody Service, using proven MorphoSys AG’s recombinant antibody technology providing high quality monoclonal antibodies in just 10 weeks.The HuCAL GOLD library contains over 15 billion unique human antibody genes in Fab format. This wealth and diversity of sequences is coupled with proprietary automated screening techniques and advanced data management systems to quickly identify the best antibody for your antigen. Monoclonal antibody generation takes place completely in vitro and involves no animals

- More than 15 billion individual antibody specificities available for screening
- Monoclonal antibodies will be delivered in just 10 weeks.
- As little as 0.5mg of protein is needed as antigen
- Optimized antigen expression from DNA
- High-affinity antibody formats show low background
- Antibodies are supplied ready-tagged for further analysis